- Mutual Funds
- Tata Mutual Fund
- Tata India Pharma & Healthcare Fund (G)
Tata India Pharma & Healthcare Fund (G)
₹ 29.17
NAV (May 13)
Sectoral / Thematic - Pharma And Healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).
The pharma benchmark index itself has been a material underperformer over an extended time frame.
Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.
Scheme Information
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Expense Ratio | 2.19 % |
Launched 9Y ago | 2015-12-28 |
AUM in Crores | 1222.7 |
ISIN | INF277K016A9 |
Lock-in (days) | No Lock-in |
Benchmark | NIFTY Pharma Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | - |
Standard Deviation | 16.5 |
Beta | 1 |
Sharpe Ratio | 0.7 |
YTM | - |
Fund Managers
Asset allocation and Holdings
Top Stock Holdings
Sun Pharmaceutical Industries Ltd.
13.1%Aurobindo Pharma Ltd.
10.06%Lupin Ltd.
9.24%Dr. Reddy's Laboratories Ltd.
6.88%Cipla Ltd.
6.07%
Allocation by Sector
Healthcare
94.45%Services
2.39%Chemicals
1.21%
Comparison with Equity Funds
| Fund Name | Fund Size | |
|---|---|---|
₹ 24,326 cr | ||
₹ 68,033 cr | ||
₹ 16,637 cr | ||
₹ 51,111 cr | ||
₹ 28,506 cr |
Tata India Pharma & Healthcare Fund (G) Review
Tata India Pharma & Healthcare Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 12% over 9 years. The fund has grown over a period of 9 years. The fund is managed by Tata Mutual Fund. The fund managers are Meeta Shetty, Rajat Srivastava.
Nav of Tata India Pharma & Healthcare Fund (G) as of 5/13/2025 is ₹29.17 with the total AUM as of 5/14/2025 is ₹1222.72. With Scripbox you can compare and check the latest nav for all mutual funds in India. Tata India Pharma & Healthcare Fund (G) was launched on 2015-12-28. The category risk of the fund is Very High.
The minimum SIP amount for Tata India Pharma & Healthcare Fund (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.
Tata India Pharma & Healthcare Fund (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to NIFTY Pharma Total Return Index.
Scripbox has rated it 1 star, indicating it's not a recommended fund in the Equity category and delivered 16.61% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Tata India Pharma & Healthcare Fund (G).